MCID: DYS009
MIFTS: 33

Dysthymic Disorder malady

Category: Mental diseases

Aliases & Classifications for Dysthymic Disorder

About this section

Aliases & Descriptions for Dysthymic Disorder:

Name: Dysthymic Disorder 10 12 36 65
 
Dysthymia 10 47

Classifications:



External Ids:

Disease Ontology10 DOID:12139
ICD1027 F34.1
ICD9CM29 300.4
SNOMED-CT59 192384008, 78667006
MeSH36 D019263
NCIt42 C34562
UMLS65 C0013415

Summaries for Dysthymic Disorder

About this section
Wikipedia:68 Dysthymia (/dɪsˈθaɪmiə/ dis-THY-mee-ə, from Ancient Greek δυσθυμία, \"bad state of... more...

MalaCards based summary: Dysthymic Disorder, also known as dysthymia, is related to lymphadenitis and ring chromosome 14 syndrome. An important gene associated with Dysthymic Disorder is HTR2A (5-Hydroxytryptamine Receptor 2A), and among its related pathways are Monoamine Transport and SIDS Susceptibility Pathways. Affiliated tissues include brain, testes and spinal cord, and related mouse phenotypes are integument and homeostasis/metabolism.

Disease Ontology:10 A mood disorder that involves the presence of a low mood almost daily over a span of at least two years.

Related Diseases for Dysthymic Disorder

About this section

Diseases related to Dysthymic Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 189)
idRelated DiseaseScoreTop Affiliating Genes
1lymphadenitis29.8GATA3, HTR2A, MAOA, SLC6A4
2ring chromosome 14 syndrome10.4HTR2A, MAOA
3ehrlichiosis10.4HTR2A, MAOA
4kleptomania10.4HTR2A, MAOA
5miller fisher syndrome10.4GATA3, HTR2A
6neurotic disorder10.3
7deafness and myopia10.3HTR2A, MAOA
8endometrial small cell carcinoma10.3GATA3, HTR2A
9lung cancer10.3
10thyroiditis10.3
11nodular episcleritis10.3CRH, HTR2A
12acute sphenoidal sinusitis10.2CRH, HTR2A
13multiple personality disorder10.2HTR2A, SLC6A4
14neurodegeneration with optic atrophy, childhood onset10.2HTR2A, SLC6A4
15kluver-bucy syndrome10.2HTR2A, SLC6A4
16prostate adenocarcinoma10.2HTR2A, SLC6A4
17uterine corpus adenomatoid tumor10.2HTR2A, SLC6A4
18exostosis10.2HTR2A, SLC6A4
19geniculate herpes zoster10.2HTR2A, SLC6A4
20cat-scratch disease10.2MAOA, SLC6A4
21tuberculosis10.2
22infertility10.2
23hereditary myopathy with lactic acidosis due to iscu deficiency10.2MAOA, SLC6A4
24intracranial aneurysm10.2MAOA, SLC6A4
25tabes dorsalis10.1HTR2A, SLC6A4
26neonatal myasthenia gravis10.1HTR2A, SLC6A4
27liver leiomyoma10.1HTR2A, HTR7
28hairy cell leukemia10.1CRH, HTR2A, MAOA
29personality disorder10.1CRH, HTR2A, MAOA
30coronary thrombosis10.1HTR2A, HTR7
31steatorrhea10.1HTR2A, HTR7
32heroin dependence10.1HTR2A, SLC6A4
33inner ear disease10.1HTR2A, HTR7
34bladder lateral wall cancer10.1HTR2A, HTR7
35panuveitis10.1HTR2A, HTR7
36conjunctiva squamous cell carcinoma10.1HTR2A, HTR7
37c1 inhibitor deficiency10.1HTR2A, HTR7
38periampullary adenoma10.1HTR2A, SLC6A4
39adrenal cortical adenoma10.1HTR2A, MAOA
40acute dacryocystitis10.1MAOA, SLC6A4
41gastric pylorus carcinoma10.1HTR2A, HTR7
42lactocele10.1HTR2A, HTR7
43rheumatoid arthritis10.0
44hiv-110.0
45hepatocellular carcinoma10.0
46asthma10.0
47fibrodysplasia ossificans progressiva10.0
48breast cancer10.0
49coronary artery disease10.0
50cleidocranial dysplasia10.0

Graphical network of the top 20 diseases related to Dysthymic Disorder:



Diseases related to dysthymic disorder

Symptoms for Dysthymic Disorder

About this section

Drugs & Therapeutics for Dysthymic Disorder

About this section

Drugs for Dysthymic Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 89)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
NorepinephrineapprovedPhase 4, Phase 259551-41-2439260
Synonyms:
(-)-(R)-Norepinephrine
(-)-Arterenol
(-)-Arterenol free base
(-)-NORADRENALINE
(-)-Noradrenaline
(-)-Norepinephrine
(-)-alpha-(Aminomethyl)protocatechuyl alcohol
(R)-(-)-Norepinephrine
(R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
(R)-Noradrenaline
(R)-Norepinephrine
1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)- (9CI)
4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol
4899-05-2
51-40-1 (l-tartrate (1:1))
51-41-2
66197-73-7
A7257_SIGMA
AC1L96ZT
ALBB-006229
Adrenor
Aktamin
Arterenol
BRN 4231961
BSPBio_002079
C00547
CHEBI:18357
CHEMBL1437
CID439260
D-(-)-Noradrenaline
D00076
D53D5E3A-2360-4CA9-8031-6C2CD4062FD5
DB00368
DivK1c_000230
EINECS 200-096-6
HMS1920B08
HMS2089E18
HMS2091J08
HMS500L12
IDI1_000230
KBio1_000230
KBio2_001489
KBio2_004057
KBio2_006625
KBio3_001579
KBioGR_000635
KBioSS_001489
L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
L-3,4-Dihydroxyphenylethanolamine
L-3,4-dihydroxyphenylethanolamine
L-Arterenol
L-Noradrenaline
L-Norepinephrine
L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol
L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol
L-arterenol
L-noradrenaline
LS-42676
 
LT03330026
LT4
Levarterenol
Levarterenolo
Levarterenolo [DCIT]
Levoarterenol
Levonor
Levonoradrenaline
Levonorepinephrine
Levophed
NCGC00159406-02
NCGC00159406-03
NCGC00159406-04
NCGC00159406-05
NCGC00159406-06
NCGC00159406-07
NCGC00159406-09
NINDS_000230
Nor adrenalin
Nor adrenalin (TN)
Nor-Epirenan
Noradrenalin
Noradrenalina
Noradrenalina [Italian]
Noradrenaline
Noradrenaline (JP15)
Noradrenalinum
Norartrinal
Noreinefrina
Noreinefrina [INN-Spanish]
Norepinefrina
Norepinephrine
Norepinephrine (INN)
Norepinephrine Noradrenalin
Norepinephrine [INN:JAN]
Norepinephrine l-Tartrate (1:1)
Norepinephrinum
Norepinephrinum [INN-Latin]
Norepirenamine
PDSP1_001111
PDSP2_001095
SGCUT00123
SPBio_001048
SPECTRUM1500436
STK503776
Spectrum2_001064
Spectrum3_000520
Spectrum4_000078
Spectrum5_001068
Spectrum_001009
Sympathin E
UNII-X4W3ENH1CV
bmse000404
l-1-(3,4-Dihydroxyphenyl)-2-aminoethanol
l-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
nchembio.284-comp2
nchembio.64-comp2
nchembio705-1
noradrenaline
norepinefrina
norepinephrine
norepinephrinum
to_000024
2
Paroxetineapproved, investigationalPhase 4, Phase 222161869-08-743815
Synonyms:
(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-methylenedioxy)phenoxy)methyl)piperidine
(-)-Paroxetine
(-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)piperidine
(-)-trans-4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl]-piperidine
(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine
(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine
(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
(3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
(3S-trans)-3-[(1,3-Benzodioxol-5-yl-oxy)methyl]-4-(4-fluorophenyl)piperidine
110429-35-1
3-(Benzo[1,3]Dioxol-5-Yl-Oxymethyl)-4-(4-Fluoro-Phenyl)-Piperidine Hydrochloride
61869-08-7
63952-24-9
64006-44-6 (maleate)
78246-49-8 (hydrochloride)
AB00514724
AC1L2AKL
AC1Q1H18
AC1Q4LV6
Aropax
BIDD:GT0673
BPBio1_000949
BRD-K37991163-003-02-7
BRL 29060
BRL-29060
BSPBio_000861
Brisdelle
C07415
C19H20FNO3
CHEBI:7936
CHEMBL490
CID43815
Casbol
D02362
DB00715
DivK1c_006884
FG 7051
FG-7051
FT-0085087
Frosinor
 
HMS2090H05
I14-7752
KBio1_001828
KBio2_002232
KBio2_004800
KBio2_007368
KBioSS_002232
LS-114249
MolPort-003-849-791
Motivan
NCGC00025355-02
NCGC00025355-03
NCGC00025355-04
NCGC00025355-05
NCGC00025355-06
NCGC00025355-07
NCGC00025355-08
NNC-20-7051
Paroxetina
Paroxetina [INN-Spanish]
Paroxetine
Paroxetine (TN)
Paroxetine (USP/INN)
Paroxetine Hcl
Paroxetine Hydrochloride
Paroxetine Mesylate
Paroxetine [USAN:INN:BAN]
Paroxetinum
Paroxetinum [INN-Latin]
PaxPar
Paxetil
Paxil
Paxil CR
Pexeva
Prestwick3_000851
Seroxat
Seroxat CR
SpecPlus_000788
Spectrum5_001665
Spectrum_001752
TL8003967
UNII-41VRH5220H
[3H]Paroxetine
paroxetine
3
ImipramineapprovedPhase 42750-49-73696
Synonyms:
1-(3-Dimethylaminopropyl)-4,5-dihydro-2,3,6,7-dibenzazepine
10,11-Dihydro-5-(3-(dimethylamino)propyl)-5H-dibenz[b,f]azepine
10,11-Dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine
10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine
113-52-0 (mono-hydrochloride)
2,2'-(3-Dimethylaminopropylimino)bibenzyl
2,2'-(3-Dimethylaminopropylimino)dibenzyl
3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine
3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine
3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine
5,6-Dihydro-N-(3-(dimethylamino)propyl)-11H-dibenz(b,e)azepine
5,6-Dihydro-N-[3-(dimethylamino)propyl]-11H-dibenz[b,e]azepine
5-(3-(Dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine
5-(3-Dimethylaminopropyl)-10,11-dihydro-5H-dibenzo(b,f)azepine
5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine
50-49-7
5H-Dibenz(b,f)azepine,5-[3-(dimethylamino)propyl]-10,11-dihydro-mixed with ethyl alcohol
5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N-dimethyl- (9CI)
AB00053486
AC1L1GIE
Antideprin
BIDD:GT0116
BPBio1_000313
BRD-K38436528-003-05-5
BRN 0256892
BSPBio_000283
BSPBio_002172
Berkomine
C07049
CAS-113-52-0
CCRIS 9173
CHEBI:47499
CHEMBL11
CID3696
CPD-11438
Censtim
Censtin
Chimoreptin
D08070
DB00458
DB08002
DPID
Declomipramine
Dimipressin
DivK1c_000559
Dpid
Dyna-Zina
Dyna-zina
Dynaprin
EINECS 200-042-1
Estraldine
Eupramin
Feinalmin
G-22355
HMS2089G08
HSDB 3100
IDI1_000559
IM
Imavate
Imidobenzyle
Imilanyle
Imipramin
Imipramina
Imipramina [INN-Spanish]
Imipramina [Italian]
Imipramine
Imipramine (INN)
Imipramine Hcl
Imipramine Hydrochloride
Imipramine Pamoate
Imipramine [INN:BAN]
Imipraminum
Imipraminum [INN-Latin]
Imiprin
Imizin
Imizine
Imizinum
 
Impramine
InChI=1/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H
Intalpram
Iramil
Irmin
Janimine
Janimine (hydrochloride)
KBio1_000559
KBio2_001395
KBio2_003963
KBio2_006531
KBio3_001392
KBioGR_000391
KBioSS_001395
L000739
LS-60467
Lofepramine
Lopac-I-7379
Lopac0_000702
Melipramin
Melipramine
MolPort-001-783-692
N-(.gamma.-Dimethylaminopropyl)iminodibenzyl
N-(3-Dimethylaminopropyl)-o-iminodibenzyl
N-(gamma-Dimethylaminopropyl)iminodibenzyl
N-(γ-dimethylaminopropyl)iminodibenzyl
NCGC00015563-01
NCGC00015563-02
NCGC00015563-03
NCGC00015563-09
NCGC00024253-03
NCGC00024253-04
NINDS_000559
NSC 169866
NSC169866
Nelipramin
Norchlorimipramine
Norfranil
Oprea1_200908
Pramine
Prazepine
Presamine
Prestwick0_000072
Prestwick1_000072
Prestwick2_000072
Prestwick3_000072
Promiben
Psychoforin
SK-Pramine
SPBio_001059
SPBio_002204
Sk-Pramine
Spectrum2_000990
Spectrum3_000466
Spectrum4_000016
Spectrum5_000864
Spectrum_000915
Surmontil
Surplix
Teperine
Timolet
Tipramine
Tofranil
Tofranil (TN)
Tofranil (free base)
Tofranil (hydrochloride)
Tofranil base
Tofranil, Base
Tofranil, base
Tofranil-PM (imipramine pamoate)
Tofranil-Pm
Tofranil-pm
Tofraniln A
Trimipramine Maleate
UNII-OGG85SX4E4
WLN: T C676 BN&T&J B3N1&1
imipramine
nchembio747-comp8
4
CitalopramapprovedPhase 4, Phase 2, Phase 349459729-33-82771
Synonyms:
1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile
1,3-dihydro[3,4]benzofuran-5-carbonitrile
1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile
59729-33-8
AB00513896
AC-12214
AC1L1EFH
AE-641/00603021
Akarin
BPBio1_000929
BRD-A47598013-004-02-0
BSPBio_000843
Bonitrile
C07572
C20H21FN2O
CHEBI:3723
CHEMBL549
CID2771
CPD000465669
Celapram
Celexa
Celius
Ciazil
Cilift
Cipram
Cipramil
Ciprapine
Citabax
Citadur
Citadur (TN)
Citalec
Citalopram
Citalopram (USP/INN)
Citalopram Hydrobromide
Citalopram [Celexa]
Citalopram [INN:BAN]
Citalopram hydrobromide
Citalopramum
Citalopramum [INN-Latin]
 
Citol
Citopam
Citox
Citrol
Cytalopram
D07704
DB00215
Dalsan
EINECS 261-891-1
Elopram
HMS2090O09
HMS2093A14
Humorup
I01-0382
InChI=1/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3
L001223
LS-84327
Lopac0_000258
Lu 10-171
Lu-10-171
MolPort-003-666-794
NCGC00015267-07
NCGC00025160-02
Nitalapram
Oropram
Perrigo Citalopram
Pramcit
Prestwick3_000692
Recital
SAM002589960
ST069372
STL058639
Seropram
Talam
Talohexal
Temperax
UNII-0DHU5B8D6V
Vodelax
Zentius
Zetalo
[3H]Citalopram
citalopram
5
Modafinilapproved, investigationalPhase 419268693-11-84236
Synonyms:
Dea No. 1680
Modafinil
Modafinil [USAN:INN]
Modafinil [Usan:Inn]
Modafinilo
Modafinilo [Spanish]
 
Modafinilum
Modafinilum [Latin]
Moderateafinil
Modiodal
Provigil
Sparlon
modafinil
6
SertralineapprovedPhase 4, Phase 2, Phase 328279617-96-268617
Synonyms:
(+)-Sertraline
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine
(1S,4S)-Sertraline
(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
(1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine
79559-97-0 (Hydrochloride)
79617-96-2
AB00514002
AB1004870
AC-15639
AC1L2A41
AC1Q3O5N
AC1Q3XJU
Apo-Sertraline
BIDD:GT0768
BIDD:PXR0193
BPBio1_001285
BRD-K82036761-003-02-1
BRN 5753709
BSPBio_001167
BSPBio_002698
C07246
C17H17Cl2N
CHEBI:9123
CHEMBL809
CID68617
CP 51974
Cp 51974
D02360
DB01104
DB08567
FT-0081122
HSDB 7037
KBio3_001918
 
KBioGR_001724
LS-94179
Lustral
MLS001195647
MLS002222308
MolPort-002-885-860
NCGC00092386-03
NCGC00092386-04
NCGC00092386-05
NCGC00092386-06
NCGC00092386-07
NCGC00092386-08
NCGC00092386-09
Prestwick3_001014
SMR000596516
SPBio_000385
SRE
Sertralina
Sertralina [Spanish]
Sertraline
Sertraline (INN)
Sertraline Hydrochloride
Sertraline [INN:BAN]
Sertraline [Zoloft]
Sertraline hydrochloride
Sertralinum
Sertralinum [Latin]
Spectrum2_000493
Spectrum3_001079
Spectrum4_001232
Sultamicillin Tosylate
UNII-QUC7NX6WMB
Zoloft
cis-(+)-Sertraline
sertraline
sertraline (Zoloft)
7
FluoxetineapprovedPhase 4, Phase 2, Phase 322954910-89-33386
Synonyms:
(+) or (-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine
(+) or (-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine
(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine
(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine
(+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine
(+/-)-Fluoxetine
(+/-)-N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine
(+/-)-N-Methyl-3-p-(p-trifluoromethylphenoxy)-3-phenylpropylamine
(+/-)-N-Methyl-3-phenyl-3-[(alpha,alpha,alpha-trifluoro-p-tolyl)oxy]propylamine
(+/-)-N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propylamine]
(+/-)-N-Methyl-gamma-[4-(trifluoromethyl)phenoxy]benzenepropanamine
3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine
52341-67-0
54910-89-3
57226-07-0
59333-67-4 (hydrochloride)
AB00053774
AC-14564
AC1L1FTH
AKOS003663021
Adofen
Animex-On
BPBio1_000354
BPBio1_000509
BRD-A31159102-001-01-9
BRD-A31159102-003-05-6
BSPBio_000461
BSPBio_003375
Bio-0787
Biomol-NT_000152
C17H18F3NO
CHEBI:5118
CHEMBL41
CID3386
D00326
DB00472
Deprex
DivK1c_006819
Eufor
Floxetine
Fluctin
Fluoxeren
Fluoxetin
Fluoxetina
Fluoxetina [INN-Spanish]
Fluoxetina [Spanish]
Fluoxetine
Fluoxetine (TN)
Fluoxetine (USAN/INN)
Fluoxetine Hcl
Fluoxetine Hydrochloride
Fluoxetine [USAN:INN:BAN]
Fluoxetinum
 
Fluoxetinum [INN-Latin]
Fluoxétine
Fluval
Fontex
Foxetin
HMS2090H14
KBio1_001763
KBio2_002159
KBio2_004727
KBio2_007295
KBio3_002595
KBioGR_001166
KBioSS_002159
L000931
LS-31040
Lilly-110140
Lopac0_000558
Methyl({3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl})amine
Methyl-[3-phenyl-3-(4-trifluoromethyl-phenoxy)-propyl]-amine
MolPort-001-683-482
N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine
N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine
N-methyl-3-phenyl-3-{[4-(trifluoromethyl)phenyl]oxy}propan-1-amine
NCGC00015428-10
NCGC00024879-03
NCGC00024879-04
NSC283480
Portal
Prestwick0_000511
Prestwick1_000511
Prestwick2_000511
Prestwick3_000511
Prozac
Prozac Weekly
Pulvules
Reconcile
Reneuron
SPBio_001815
SPBio_002382
STK734483
Sarafem
SpecPlus_000723
Spectrum2_001658
Spectrum3_001648
Spectrum4_000613
Spectrum5_001518
Spectrum_001679
TL8003595
UNII-01K63SUP8D
dl-3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine
fluoxetine
fluoxetine (Prozac)
nchembio.534-comp2
8
BupropionapprovedPhase 4, Phase 2, Phase 330834841-39-9444
Synonyms:
( -)-2-(tert-Butylamino)-3'-chloropropiophenone
( -)-2-(tert-Butylamino)-3'-chlorpropiophenon
(+-)-1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone
(+-)-Bupropion
.alpha.-(tert-Butylamino)-m-chloropropiophenone
1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]propan-1-one
2-(Tert-Butylamino)-3'-chloropropiophenone
2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one
34841-36-6 (hydrochloride)
34841-39-9
34911-55-2
AB00053756
AC-197
AC1L198Y
AMFEBUTAMONE HCl
Amfebutamon
Amfebutamona
Amfebutamona [INN-Spanish]
Amfebutamone
Amfebutamonum
Amfebutamonum [INN-Latin]
Aplenzin
BPBio1_000042
BRD-A05186015-003-05-7
BRN 2101062
BSPBio_000038
BSPBio_002247
Budeprion
Buproban
Bupropion
Bupropion (INN)
Bupropion (Old RN)
Bupropion (USAN)
Bupropion Hcl
Bupropion Hydrochloride
Bupropion SR
Bupropion [INN:BAN]
Bupropion hydrocloride
C06860
CHEBI:3219
CHEMBL894
CID444
CPD000472526
D07591
DB01156
 
DivK1c_007050
Elont
HMS2051G10
HMS2089G14
Jsp006301
KBio1_001994
KBio2_002143
KBio2_004711
KBio2_007279
KBio3_001467
KBioGR_001168
KBioSS_002143
L000725
LS-122817
Lopac0_000166
MLS001424015
MolPort-003-845-432
NCGC00015122-06
NCGC00089751-02
NCI60_002714
NSC315851
Prestwick0_000249
Prestwick1_000249
Prestwick2_000249
Prestwick3_000249
SAM001246699
SMR000472526
SPBio_001817
SPBio_002257
SpecPlus_000954
Spectrum2_001659
Spectrum3_000644
Spectrum4_000614
Spectrum5_001406
Spectrum_001663
TL8002604
UNII-01ZG3TPX31
Wellbatrin
Wellbutrin
Wellbutrin SR
Wellbutrin XL
Wellbutrin Xl
Zyban
alpha-(tert-butylamino)-m-chloropropiophenone
amfebutamonum
bupropion
9
DopamineapprovedPhase 4308462-31-7, 51-61-6681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine Hcl
Dopamine Hydrochloride
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
 
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
10
Testosteroneapproved, investigationalPhase 447458-22-06013
Synonyms:
(+)-testosterone
(+-)-8-iso-testosterone
(+-)-retrotestosterone
(+-)-testosterone
(17b)-17-hydroxy-androst-4-en-3-one
(17beta)-17-Hydroxyandrost-4-en-3-one
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
13-Iso-testosterone
17-Hydroxy-(17-beta)-androst-4-en-3-one
17-Hydroxy-(17beta)-androst-4-en-3-one
17-Hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one
17-Hydroxy-D4-androsten-3-one
17-Hydroxy-androst-4-en-3-one
17-beta-Hydroxy-delta(sup 4)-androsten-3-one
17-beta-Hydroxyandrost-4-en-3-one
17?-Hydroxy-4-androsten-3-one
17a-Hydroxy-(13a)-androst-4-en-3-one
17a-Hydroxy-13a-androst-4-en-3-one
17a-Hydroxy-14b-androst-4-en-3-one
17a-Hydroxy-androst-4-en-3-one
17b-Hydroxy-(10a)-androst-4-en-3-one
17b-Hydroxy-(13a)-androst-4-en-3-one
17b-Hydroxy-(8a)-androst-4-en-3-one
17b-Hydroxy-(8a,10a)-androst-4-en-3-one
17b-Hydroxy-(9b)-androst-4-en-3-one
17b-Hydroxy-(9b,10a)-androst-4-en-3-one
17b-Hydroxy-13a-androst-4-en-3-one
17b-Hydroxy-8a-androst-4-en-3-one
17b-Hydroxy-D4-androsten-3-one
17b-Hydroxy-androst-4-en-3-on
17b-Hydroxy-androst-4-en-3-one
17b-Hydroxyandrost-4-en-3-one
17b-Hydroxyandrost-4-ene-3-one
17b-Testosterone
17b-hydroxy-4-androsten-3-one
17beta-Hydroxy-3-oxo-4-androstene
17beta-Hydroxy-4-androsten-3-one
17beta-Hydroxy-delta(sup4)-androsten-3-one
17beta-Hydroxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-ene-3-one
17beta-hydroxy-4-androsten-3-one
4-Androsten-17?-ol-3-one
4-Androsten-17beta-ol-3-one
4-Androsten-3-one-17b-ol
4-androsten-17β-ol-3-one
4-androstene-17beta-ol-3-one
46923_FLUKA
46923_RIEDEL
58-22-0
7-beta-Hydroxyandrost-4-en-3-one
8-Iso-testosterone
9b,10a-Testosterone
9b-Testosterone
AA 2500
AC-14899
AC1L1LM0
Andriol
Andro
Andro 100
Andro L.A. 200
AndroGel
Androderm
Androderm (TN)
Androgel
Androgel (TN)
Android 10
Android 25
Android 5
Androlin
Andronaq
Andronate 100
Andronate 200
Andropatch
Andropository 200
Androsorb
Androst-4-en-17b-ol-3-one
Androst-4-en-17beta-ol-3-one
Androst-4-ene-17b-ol-3-one
Andrusol
Andryl 200
Aveed
Axiron
B5DEE83F-632B-48A1-A0ED-A51E7F13DF2E
BIDD:ER0555
BIM-0061761.0001
Beta Testosterone
Bio-0678
Bio-T-Gel
C00535
CCRIS 574
CDB 111C
CHEBI:17347
CHEMBL386630
CID6013
CMC_13449
COL 1621
CP 601B
CPD000058344
Cristerona T
Cristerone T
D00075
D4-Androsten-17b-ol-3-one
DB00624
Dea No. 4000
Delatest
Delatestryl
Depo-Testadiol
Depo-Testosterone
Depo-Testosterone Cypionate
Depo-testosterone
Depotest
EINECS 200-370-5
Epitestosteron
Everone 200
Fortesta
Geno-Cristaux Gremy
Geno-cristaux Gremy
Geno-cristaux gremy
HMS2052N11
HSDB 3398
Halotensin
Homosteron
Homosterone
Intrinsa
 
LMST02020002
LS-148813
LibiGel
Libigel
Lumitestosteron
MLS000563091
MLS001032098
MLS001306401
MLS002174283
Malerone
Malestrone
Malestrone (amps)
Malogen in Oil
Malogen, Aquaspension Injection
Malogen, aquaspension injection
Mertestate
Metandren
Methyltestosterone
MolPort-002-506-901
NCGC00091018-01
NSC 9700
Natesto nasal gel
Neo-Hombreol F
Neo-Testis
Neo-testis
Neotestis
Oreton
Oreton F
Oreton Methyl
Oreton-F
Orquisteron
Perandren
Percutacrine Androgenique
Percutacrine androgenique
Primotest
Primoteston
Rac-17b-hydroxy-(13a)androst-4-en-3-one
Rac-17b-hydroxy-(8a)-androst-4-en-3-one
Rac-17b-hydroxy-(9b,10a)androst-4-en-3-one
Rac-17b-hydroxy-androst-4-en-3-one
Relibra
Retrotestosterone
S00309
S2033_Selleck
SAM001246921
SMR000058344
SMR001261453
Scheinpharm Testone-Cyp
Striant
Striant (TN)
Sustanon
Sustanone
Sustason 250
Synandrol F
T-Cypionate
T1500_SIGMA
T5411_FLUKA
T5411_SIGMA
TES
Teslen
Testamone 100
Testandrone
Testaqua
Testiculosterone
Testim
Testim (TN)
Testobase
Testoderm
Testoderm Tts
Testogel
Testoject-50
Testolent
Testolin
Testopel
Testopel Pellets
Testopropon
Testosteroid
Testosteron
Testosterona
Testosterona [INN-Spanish]
Testosterone
Testosterone (JAN/USP)
Testosterone Cypionate
Testosterone Enanthate
Testosterone Gel
Testosterone Heptanoate
Testosterone Hydrate
Testosterone Propionate
Testosterone Undecanoate
Testosterone [Androgenic steroids, anabolic]
Testosterone [INN:BAN]
Testosterone and its esters
Testosterone hydrate
Testosterone solution
Testosteronum
Testosteronum [INN-Latin]
Testostosterone
Testostérone
Testoviron
Testoviron Schering
Testoviron T
Testoxyl
Testred
Testred Cypionate 200
Testrin-P.A
Testro AQ
Testro Aq
Testrone
Testryl
Tostrelle
Tostrex
Trans-Testosterone
UNII-3XMK78S47O
Viatrel
Virilon
Virilon IM
Virormone
Virosterone
Vogelxo
ZINC06500184
beta testosterone
delta(sup 4)-Androsten-17(beta)-ol-3-one
delta4-Androsten-17beta-ol-3-one
delta4-androsten-17b-ol-3-one
testosterone
trans-Testosterone
11
MethyltestosteroneapprovedPhase 447458-18-46010
Synonyms:
17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one
17-Methyltestosterone
17-beta-Hydroxy-17-methylandrost-4-en-3-one
17-methyltestosterone
17alpha-Methyl-3-oxo-4-androsten-17beta-ol
17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one
17alpha-Methyltestosterone
17alpha-methyl-delta-androsten-17beta-ol-3-one
17alpha-methyltestosterone
17beta-Hydroxy-17-methylandrost-4-en-3-one
 
17α-methyl-Δ4-androsten-17β-ol-3-one
17α-methyltestosterone
4-Androstene-17alpha-methyl-17beta-ol-3-one
Android
Methitest
Methyltestosterone
Methyltestosteronum
Metiltestosterona
NSC-9701
Testred
Testred C-III
Virilon
12
DonepezilapprovedPhase 4271120014-06-43152
Synonyms:
( inverted exclamation markA)-E 2020
1-Benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine
120014-06-4
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one
AB1004836
AC-6969
AC1L1FAE
AKOS000277311
Aricept
Aricept ODT
C24H29NO3
CHEBI:53289
CHEMBL502
CID3152
D07869
DB00843
Domepezil
Donaz
Donaz (TN)
 
Donepezil
Donepezil (INN)
Donepezil Hydrochloride
Donepezil [INN:BAN]
Donepezil hydrochloride
Donepezilo
Donepezilum
Eranz
I06-0343
KBio2_002144
KBio2_004712
KBio2_007280
KBioSS_002144
LS-81819
MolPort-000-881-588
MolPort-003-847-014
NCGC00167537-01
Oprea1_188452
Spectrum5_001662
Spectrum_001664
TL8000531
UNII-8SSC91326P
13Antidepressive Agents, TricyclicPhase 4250
14Adrenergic AgentsPhase 4, Phase 24204
15Contraceptives, OralPhase 4, Phase 23734
16Wakefulness-Promoting AgentsPhase 4179
17Tranquilizing AgentsPhase 4, Phase 3, Phase 23597
18Venlafaxine HydrochloridePhase 4, Phase 2, Phase 3185
19Phosphodiesterase 5 InhibitorsPhase 4513
20Sildenafil CitratePhase 4304171599-83-0
21Vasodilator AgentsPhase 42926
22Antipsychotic AgentsPhase 42130
23Central Nervous System StimulantsPhase 4, Phase 1, Phase 21721
24Desvenlafaxine SuccinatePhase 467386750-22-7
25Antidepressive AgentsPhase 4, Phase 3, Phase 2, Phase 12367
26Phosphodiesterase InhibitorsPhase 41062
27Central Nervous System DepressantsPhase 4, Phase 3, Phase 210016
28Serotonin AgentsPhase 4, Phase 3, Phase 22668
29Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 114795
30Neurotransmitter Uptake InhibitorsPhase 4, Phase 3, Phase 22857
31Psychotropic DrugsPhase 4, Phase 3, Phase 2, Phase 15501
32AnalgesicsPhase 49358
33Dopamine Uptake InhibitorsPhase 4925
34Dopamine AgentsPhase 43084
35Antidepressive Agents, Second-GenerationPhase 4, Phase 21087
36Cytochrome P-450 CYP2D6 InhibitorsPhase 4602
37Cytochrome P-450 Enzyme InhibitorsPhase 43036
38Duloxetine HydrochloridePhase 4258
39Peripheral Nervous System AgentsPhase 4, Phase 2, Phase 118510
40Muscarinic AntagonistsPhase 4, Phase 2961
41ParasympatholyticsPhase 4, Phase 2902
42Serotonin Uptake InhibitorsPhase 4, Phase 3, Phase 21369
43ArmodafinilPhase 4192
44Cholinergic AntagonistsPhase 4, Phase 21423
45
SerotoninPhase 4, Phase 3, Phase 2314750-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
46Cholinergic AgentsPhase 4, Phase 2, Phase 13243
47Serotonin and Noradrenaline Reuptake InhibitorsPhase 4, Phase 2391
48Antiparkinson AgentsPhase 4, Phase 21312
49
Testosterone enanthatePhase 4474315-37-79416
Synonyms:
17-((1-Oxoheptyl)oxy)androst-4-en-3-one
17-Hydroxyandrost-4-en-3-one, 17-heptanoate
17-Hydroxyandrost-4-en-3-one, 17-heptanoic acid
17beta-Enanthoxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-en-3-one enanthate
4-Androsten-17beta-ol-3-one 17-enanthate
4-Androsten-3-one 17beta-enanthate
Androgyn L.A.
Andropository
Androtardyl
Atlatest
DEA No. 4000
DePatestrye
Delatest
Delatestryl
Depo-Testro Med
Ditate
Durathate
Everone
 
Exten test
Malogen L.A.
Malogen L.A.200
Orquisteron-E
Primotestone
Reposo TMD
Testanthate
Testate
Testenate
Testinon
Testoenant
Testonenant
Testosterone 17-enanthate
Testosterone 17beta-heptanoate
Testosterone 17beta-heptanoic acid
Testosterone enantate
Testosterone heptoate
Testosterone heptoic acid
Testosterone heptylate
Testosterone oenanthate
Testostroval
50Testosterone undecanoatePhase 4474

Interventional clinical trials:

(show top 50)    (show all 71)
idNameStatusNCT IDPhase
1Wellbutrin XL for Dysthymic DisorderCompletedNCT00225251Phase 4
2Duloxetine Treatment in Elderly With DysthymiaCompletedNCT01852383Phase 4
3Escitalopram in the Treatment of Dysthymic Disorder, Double BlindCompletedNCT00220701Phase 4
4Duloxetine for Chronic Depression: a Double-blind StudyCompletedNCT00360724Phase 4
5Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and DepressionCompletedNCT00518986Phase 4
6Project to Improve Symptoms and Mood in People With Spinal Cord InjuryCompletedNCT00592384Phase 4
7Treatment of Depression Following Multiple Brain TestsCompletedNCT00296777Phase 4
8Dichotic Listening as a Predictor of Medication Response in DepressionCompletedNCT00296725Phase 4
9Are Two Antidepressants a Good Initial Treatment for Depression?CompletedNCT00296712Phase 4
10Dichotic Listening as a Predictor of Medication Response in DepressionCompletedNCT00404755Phase 4
11A Pilot Study Assessing Duloxetine's Efficacy in Atypical DepressionCompletedNCT00296699Phase 4
12Efficacy Study Measuring The Impact Of Treatment With Viagra On The Depressive Symptoms Of Men With Erectile DysfunctionCompletedNCT00159809Phase 4
13Paroxetine - Controlled Release in the Treatment of Irritable Bowel Syndrome (IBS)CompletedNCT00610909Phase 4
14Testosterone Replacement in Middle-Aged Hypogonadal Men With Dysthymia: Parallel Group, Double Blind Randomized TrialRecruitingNCT00260390Phase 4
15Desvenlafaxine vs. Placebo Treatment of Chronic DepressionRecruitingNCT01537068Phase 4
16Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older AdultsRecruitingNCT01973283Phase 4
17Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood DisordersRecruitingNCT00182533Phase 4
18Medications for the Treatment of Dysthymic Disorder and Double DepressionActive, not recruitingNCT00234312Phase 4
19Combination Treatment Study for Memory Impairment and DepressionActive, not recruitingNCT01658228Phase 4
20Switching to Duloxetine to Ameliorate SSRI-Induced Sexual DysfunctionTerminatedNCT00398632Phase 4
21A Comparison of Medication Augmentation and PST in the Treatment of Depression in Older AdultsWithdrawnNCT01942187Phase 4
22A Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal BehaviorCompletedNCT01447602Phase 3
23A Stepped Care Model of Adolescent Depression Treatment in Primary CareCompletedNCT01443715Phase 2, Phase 3
24Safety and Tolerability of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderCompletedNCT00707980Phase 3
25Treatment of Adolescent Suicide Attempters (TASA)CompletedNCT00080158Phase 2, Phase 3
26A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}RecruitingNCT02358343Phase 3
27Treating Depression Among Low-Income Patients With CancerActive, not recruitingNCT00565110Phase 2, Phase 3
28The Efficacy of Parent Involvement in the Treatment of Adolescent DepressionCompletedNCT00883519Phase 1, Phase 2
29A Safety, Efficacy and Tolerability Study of SEP-225289CompletedNCT00584974Phase 2
30Group Therapy for Women Prisoners With Comorbid Substance Use and DepressionCompletedNCT00606996Phase 2
31Safety and Efficacy Study of Citalopram and Lithium for the Treatment of Depressive Mood Disorder SymptomsCompletedNCT01189812Phase 2
32Group Interpersonal Psychotherapy for Depressed Adolescents in School-based ClinicsCompletedNCT00270244Phase 2
33Bringing What Works to Youth in Corrections: A Trauma InterventionCompletedNCT01560728Phase 1, Phase 2
34Computerized Information-Processing Bias Retraining in Depressed AdolescentsCompletedNCT01147913Phase 2
35New Approaches to Cocaine Abuse Medications (A) - 6CompletedNCT00000271Phase 2
36A Study of Omega-3 as a Treatment for Major DepressionRecruitingNCT00238758Phase 2
37Effects of Therapist Behavior on the Treatment of Depressed AdolescentsActive, not recruitingNCT00073359Phase 1, Phase 2
38Smoking Cessation for Depressed SmokersActive, not recruitingNCT00494728Phase 1, Phase 2
39eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed PatientsEnrolling by invitationNCT02458690Phase 2
40Interpersonal Psychotherapy for Depressed Adolescents and ParentsCompletedNCT00619411Phase 1
41Motivational Interviewing to Improve Medication Adherence Among Hispanic Adults With DepressionCompletedNCT00356304Phase 1
42Desvenlafaxine Monotherapy in DysthymiaCompletedNCT01948895
43Enhanced Collaborative Depression Treatment in Primary Care: The RESPECT-D-E TrialCompletedNCT01583400
44Cognitive Behavioral Therapy (REBT/CBT) Evaluation for Dysthymia in the Practice of Clinical Social Work at Primary CareCompletedNCT02112708
45Quetiapine in Co-Morbid Depressive and Anxiety DisordersCompletedNCT00688818
46Cognitive Therapy for Unipolar Depression: Efficacy of a Dilemma-Focused InterventionCompletedNCT01542957
47Duloxetine for the Treatment of DysthymiaCompletedNCT00185575
48Improving Depression Care for Elders: Coordinating CenterCompletedNCT01561105
49Motivational Interviewing and Cognitive Behavioral Therapy-based Intervention for Cardiovascular Disease Prevention Amongst American Indians With Diabetic and Depressive SymptomsCompletedNCT01892124
50Cognitive Behavioral Therapy for Early-Onset DepressionCompletedNCT00096642

Search NIH Clinical Center for Dysthymic Disorder


Cochrane evidence based reviews: dysthymic disorder

Genetic Tests for Dysthymic Disorder

About this section

Anatomical Context for Dysthymic Disorder

About this section

MalaCards organs/tissues related to Dysthymic Disorder:

33
Brain, Testes, Spinal cord, Endothelial, Liver, T cells, Pancreatic islet

Animal Models for Dysthymic Disorder or affiliated genes

About this section

MGI Mouse Phenotypes related to Dysthymic Disorder:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00107717.7CRH, GATA3, HTR7, IKBKAP, SLC6A4
2MP:00053766.9CINP, CRH, GATA3, HTR7, IKBKAP, MAOA

Publications for Dysthymic Disorder

About this section

Articles related to Dysthymic Disorder:

(show top 50)    (show all 113)
idTitleAuthorsYear
1
Kinase activator-receiver preference in ErbB heterodimers is determined by intracellular regions and is not coupled to extracellular asymmetry. (25468910)
2015
2
Depletion of ALX1 causes inhibition of migration and induction of apoptosis in human osteosarcoma. (25736924)
2015
3
Effect of hyperglycemia and hyperinsulinemia on glutathione peroxidase activity in non-obese women with polycystic ovary syndrome. (25402379)
2014
4
Distinctive manifestations of cutaneous intraneural perineurioma of fingers, compared with typical intraneural perineurioma. (24685866)
2014
5
Bradykinin-mediated angioedema: factors prompting ED visits. (22944544)
2013
6
Serum apoptosis markers related to liver damage in chronic hepatitis C: sFas as a marker of advanced fibrosis in children and adults while M30 of severe steatosis only in children. (23326448)
2013
7
Measurement of circulating endothelial cells to support the diagnosis of veno-occlusive disease after hematopoietic stem cell transplantation. (23981391)
2013
8
Gout with auricular tophi following anti-tuberculosis treatment: a case report. (24256949)
2013
9
Prominent mucoid degeneration of the parotid gland in a patient with systemic lupus erythematosus. (24228125)
2013
10
Microvesicular fat, inter cellular adhesion molecule-1 and regulatory T-lymphocytes are of importance for the inflammatory process in livers with non-alcoholic steatohepatitis. (21635548)
2011
11
Homozygous sickle cell anemia and secondary complications: a case study. (21657139)
2011
12
Two cases of angular pregnancy complicated by preterm labor and placental abruption at mid-pregnancy. (21450029)
2011
13
Single nucleotide polymorphisms in Wnt signaling and cell death pathway genes and susceptibility to colorectal cancer. (20403915)
2010
14
Newborn screening and early biochemical follow-up in combined methylmalonic aciduria and homocystinuria, cblC type, and utility of methionine as a secondary screening analyte. (19836982)
2010
15
Defects in insulin secretion and action in the pathogenesis of type 2 diabetes mellitus. (20425581)
2010
16
TLR9 contributes to the recognition of EBV by primary monocytes and plasmacytoid dendritic cells. (20713890)
2010
17
Imported histoplasmosis: two distinct profiles in travelers and immigrants. (19674266)
2009
18
The cytosolic half of helix III forms the substrate exit route during permeation events of the sodium/bile acid cotransporter ASBT. (19653651)
2009
19
c-jun controls the ability of IL-12 to induce IL-10 production from human memory CD4+ T cells. (19734233)
2009
20
Calcium/calmodulin-dependent kinase II regulates notch-1 signaling in prostate cancer cells. (19021144)
2009
21
Aurora-C kinase supports mitotic progression in the absence of Aurora-B. (19713763)
2009
22
"Blinding" of AMP-dependent kinase by methylglyoxal: a mechanism that allows perpetuation of hepatic insulin resistance? (19643547)
2009
23
Spontaneous intracranial hypotension syndrome in a patient with marfan syndrome and autosomal dominant polycystic kidney disease. (18194297)
2008
24
Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development. (18451171)
2008
25
A +8 (-->CT) mutation within the 5' untranslated region of beta-globin down-regulates the mRNA transcription. (18473240)
2008
26
Administration of milrinone before ischemia, in the presence of beta-blockade, to treat metabolic impairment and myocardial stunning in pigs. (18269389)
2008
27
Three-dimensional quantitative structure-activity relationship of nucleosides acting at the A3 adenosine receptor: analysis of binding and relative efficacy. (17338510)
2007
28
Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk. (17620161)
2007
29
Nodal aggressive B-cell lymphomas: a diagnostic approach. (17369507)
2007
30
Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence. (15483091)
2005
31
Genes controlling the metabolic switch in hibernating mammals. (15506953)
2004
32
Homeodomain protein CDX2 regulates COX-2 expression in colorectal cancer. (15013430)
2004
33
Is anteroseptal myocardial infarction an appropriate term? (12106621)
2002
34
Characterization of the nuclear localization signal of the borna disease virus polymerase. (12134049)
2002
35
Recurrent bronchiolitis obliterans organizing pneumonia in a patient with limited cutaneous systemic sclerosis. (12215870)
2002
36
Cochlear implant for a totally deaf patient with superficial hemosiderosis of the central nervous system. (11892128)
2000
37
Association of impaired phosphatidylinositol 3-kinase activity in GLUT1-containing vesicles with malinsertion of glucose transporters into the plasma membrane of fibroblasts from a patient with severe insulin resistance and clinical features of Werner syndrome. (10690909)
2000
38
Interferon regulatory factor 1 tryptophan 11 to arginine point mutation abolishes DNA binding. (10395927)
1999
39
SRPK2: a differentially expressed SR protein-specific kinase involved in mediating the interaction and localization of pre-mRNA splicing factors in mammalian cells. (9472028)
1998
40
Rapid progression of acquired amegakaryocytic thrombocytopenia to aplastic anemia. (9003837)
1997
41
Degradation of collagen type IV by C6 astrocytoma cells. (8523079)
1995
42
Penetration of ciprofloxacin into bronchial secretions from mechanically ventilated patients with nosocomial bronchopneumonia. (8031070)
1994
43
A survey of beta-lactamases from 618 isolates of Klebsiella spp. (8444672)
1993
44
Intrathoracic extraskeletal Ewing's sarcoma: a case report and review of literature. (8281497)
1993
45
Eosinophilia-myalgia syndrome: the aftermath. (1523446)
1992
46
NMDA-receptor-independent effects of low magnesium: involvement of adenosine. (2155041)
1990
47
A distinct human testis and brain mu-class glutathione S-transferase. Molecular cloning and characterization of a form present even in individuals lacking hepatic type mu isoenzymes. (2345169)
1990
48
Xanthogranulomatous pyelonephritis. An immunohistochemical and ultrastructural study on the occurrence of bacteria and bacterial antigen. (7324298)
1981
49
The FTA-ABS test in dark-field-positive primary syphilis. (4595670)
1974
50
Case of Prurigo Alternating with Melancholia. (20744719)
1867

Variations for Dysthymic Disorder

About this section

Expression for genes affiliated with Dysthymic Disorder

About this section
Search GEO for disease gene expression data for Dysthymic Disorder.

Pathways for genes affiliated with Dysthymic Disorder

About this section

GO Terms for genes affiliated with Dysthymic Disorder

About this section

Biological processes related to Dysthymic Disorder according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1response to ethanolGO:00454719.6CRH, GATA3
2memoryGO:00076139.5HTR2A, SLC6A4
3smooth muscle contractionGO:00069399.5HTR2A, HTR7
4response to drugGO:00424938.3CRH, GATA3, HTR2A, SLC6A4

Sources for Dysthymic Disorder

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet